← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2008Last known activity
Sep 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT07030920CollaboratorPhase 2Sep 30, 2025
- NCT05430152CollaboratorPhase 2Mar 31, 2023
- NCT01527786Reponsible party - principal investigatorPhase 3Nov 1, 2010
- NCT01527786Lead sponsorPhase 3Nov 1, 2010
- NCT01527474Lead sponsorN/AApr 1, 2008
- NCT01527474Reponsible party - principal investigatorN/AApr 1, 2008
- NCT01527448Lead sponsorN/AApr 1, 2008
- NCT01527448Reponsible party - principal investigatorN/AApr 1, 2008
Details
- Last known activity
- Sep 30, 2025